Application no. and date | 15719011.7 (espacenet) (Federated) (European Patent Register), 20150410 | Patent/reg. no. and date | DK/EP 3129063, 20210127 | Publication date | 20170215 | Priority no. and date | JP 2014081454, 20140410 | EP pub. no. and date |
EP 3129063 20170215 | Effective date | | Applicant/owner | DAIICHI SANKYO COMPANY, LIMITED, 3-5-1, Nihonbashi Honcho Chuo-ku Tokyo 103-8426, JP, Daiichi Sankyo Europe GmbH, Zielstattstr. 48
81379 München, DE | Applicant ref. no. | V157222DK | Inventor | HETTMANN, Thore, c/o U3 Pharma GmbH Fraunhoferstr. 22
82152 Martinsried, DE, ABRAHAM, Reimar, c/o U3 Pharma GmbH Fraunhoferstr. 22
82152 Martinsried, DE, BLUM, Sabine, c/o U3 Pharma GmbH Fraunhoferstr. 22
82152 Martinsried, DE, UENO, Suguru, c/o DAIICHI SANKYO COMPANY, LIMITED 1-2-58 Hiromachi Shinagawa-ku
Tokyo 140-8710, JP | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 47/68 (2017.01) , A61P 35/00 (2006.01) | Title | ANTI-HER3-ANTISTOF-LÆGEMIDDELKONJUGAT | Int. application no. | JP2015002020 | Int. publication no. | WO2015155998 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|